Back to top
more

Edwards Lifesciences (EW)

(Real Time Quote from BATS)

$66.71 USD

66.71
3,335,977

+0.48 (0.73%)

Updated Nov 11, 2024 02:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Instruments

Zacks News

International Markets and Edwards Lifesciences (EW): A Deep Dive for Investors

Explore Edwards Lifesciences' (EW) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

EW Q3 Earnings Match Estimates, Revenues Miss, Stock Falls

Edwards Lifesciences reports strong contributions from all of the product groups - TAVR, TTMT and surgical structural heart - in the third quarter of 2024.

Compared to Estimates, Edwards Lifesciences (EW) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

TFX or EW: Which Is the Better Value Stock Right Now?

TFX vs. EW: Which Stock Is the Better Value Option?

Edwards Lifesciences (EW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Earnings Preview: DexCom (DXCM) Q3 Earnings Expected to Decline

DexCom (DXCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Q3 Release

Edwards Lifesciences (EW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Edwards Lifesciences to Report Q3 Earnings: What's in the Cards?

EW is likely to have witnessed continued growth in TAVR procedures across the United States and worldwide in the third quarter.

TFX vs. EW: Which Stock Is the Better Value Option?

TFX vs. EW: Which Stock Is the Better Value Option?

Is it the Right Time to Hold EW Stock in Your Portfolio Now?

Edward Lifesciences' Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.

TFX vs. EW: Which Stock Should Value Investors Buy Now?

TFX vs. EW: Which Stock Is the Better Value Option?

Why Is Globus Medical (GMED) Down 0.2% Since Last Earnings Report?

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BD Stock Falls After Acquisition of Edwards' Critical Care Group

BDX expands its smart care portfolio by acquiring Edwards Lifesciences' Critical Care group, now BD Advanced Patient Monitoring, strengthening AI-driven health solutions.

EW Stock Dips Following the Divestiture of Critical Care Wing

Edwards completes the sale of its Critical Care operations and announces a $1 billion share repurchase program.

EW Stock to Benefit From Favorable RHEIA Trial Data on TAVI

Edwards' first all-female TAVI Trial demonstrates favorable outcomes for women receiving Edwards valves.

Why Is Waters (WAT) Down 2.2% Since Last Earnings Report?

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Penumbra (PEN) Up 20% Since Last Earnings Report?

Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Hologic (HOLX) Down 3.4% Since Last Earnings Report?

Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Edwards Lifesciences (EW) Up 19.4% Since Last Earnings Report: Can It Continue?

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TFX or EW: Which Is the Better Value Stock Right Now?

TFX vs. EW: Which Stock Is the Better Value Option?

Should You Hold Edward Lifesciences (EW) in Your Portfolio Now?

Edward Lifesciences' (EW) promising TAVR business and the Critical Care divestment move bode well in the long term.

TFX or EW: Which Is the Better Value Stock Right Now?

TFX vs. EW: Which Stock Is the Better Value Option?

Edwards Lifesciences (EW) Reliance on International Sales: What Investors Need to Know

Evaluate Edwards Lifesciences' (EW) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash

Edwards Lifesciences (EW) reports strong contributions from the TMTT product group in the second quarter of 2024.

Edwards Lifesciences (EW) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Edwards Lifesciences (EW) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.